Back to Search Start Over

Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--response.

Authors :
Michieli P
Basilico C
Pennacchietti S
Source :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Aug 01; Vol. 19 (15), pp. 4291. Date of Electronic Publication: 2013 Jun 13.
Publication Year :
2013

Subjects

Subjects :
Humans
Antineoplastic Agents pharmacology
Proto-Oncogene Proteins c-met metabolism
Pyrrolidinones pharmacology
Quinolines pharmacology
Tubulin Modulators pharmacology

Details

Language :
English
ISSN :
1557-3265
Volume :
19
Issue :
15
Database :
MEDLINE
Journal :
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Type :
Report
Accession number :
23766360
Full Text :
https://doi.org/10.1158/1078-0432.CCR-13-1534
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details